Simurosertib Uses, Dosage, Side Effects and more
Simurosertib is under investigation in clinical trial NCT03261947 (A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Simurosertib |
| Generic | Simurosertib |
| Simurosertib Other Names | Simurosertib |
| Type | |
| Formula | C17H19N5OS |
| Weight | Average: 341.43 Monoisotopic: 341.131031426 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
